HK1114876A1 - Arthrospira-based compositions and uses thereof - Google Patents

Arthrospira-based compositions and uses thereof

Info

Publication number
HK1114876A1
HK1114876A1 HK08104884.3A HK08104884A HK1114876A1 HK 1114876 A1 HK1114876 A1 HK 1114876A1 HK 08104884 A HK08104884 A HK 08104884A HK 1114876 A1 HK1114876 A1 HK 1114876A1
Authority
HK
Hong Kong
Prior art keywords
arthrospira
based compositions
subject
composition
concerns
Prior art date
Application number
HK08104884.3A
Other languages
English (en)
Inventor
Kelvin Winston Duncan
Peter Owen Johnston
Ashley Michael Brown
Original Assignee
Biovite Australia Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2004906317A external-priority patent/AU2004906317A0/en
Application filed by Biovite Australia Pty Ltd filed Critical Biovite Australia Pty Ltd
Publication of HK1114876A1 publication Critical patent/HK1114876A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/748—Cyanobacteria, i.e. blue-green bacteria or blue-green algae, e.g. spirulina
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/20—Bacteria; Substances produced thereby or obtained therefrom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/005—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor after treatment of microbial biomass not covered by C12N1/02 - C12N1/08
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/06—Lysis of microorganisms
    • C12N1/066—Lysis of microorganisms by physical methods
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/12—Unicellular algae; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2434—Glucanases acting on beta-1,4-glucosidic bonds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2434—Glucanases acting on beta-1,4-glucosidic bonds
    • C12N9/2442—Chitinase (3.2.1.14)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/80—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01014—Chitinase (3.2.1.14)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01132—Chitosanase (3.2.1.132)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
    • C12Y305/01—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in linear amides (3.5.1)
    • C12Y305/01041—Chitin deacetylase (3.5.1.41)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Emergency Medicine (AREA)
  • Sustainable Development (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Botany (AREA)
  • Cell Biology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
HK08104884.3A 2004-11-03 2008-05-02 Arthrospira-based compositions and uses thereof HK1114876A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2004906317A AU2004906317A0 (en) 2004-11-03 Arthrospira-based Compositions and Uses Thereof
PCT/AU2005/001693 WO2006047830A1 (en) 2004-11-03 2005-11-03 Arthrospira-based compositions and uses thereof

Publications (1)

Publication Number Publication Date
HK1114876A1 true HK1114876A1 (en) 2008-11-14

Family

ID=36318829

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08104884.3A HK1114876A1 (en) 2004-11-03 2008-05-02 Arthrospira-based compositions and uses thereof

Country Status (17)

Country Link
US (1) US8808706B2 (ko)
EP (2) EP2502983B1 (ko)
JP (1) JP5117193B2 (ko)
KR (1) KR101350764B1 (ko)
CN (1) CN101068917B (ko)
CA (1) CA2627187C (ko)
CY (1) CY1115690T1 (ko)
DK (2) DK1814977T3 (ko)
ES (2) ES2503340T3 (ko)
HK (1) HK1114876A1 (ko)
NZ (1) NZ554897A (ko)
PL (2) PL2502983T3 (ko)
PT (1) PT1814977E (ko)
RU (1) RU2412990C2 (ko)
SI (1) SI1814977T1 (ko)
WO (1) WO2006047830A1 (ko)
ZA (1) ZA200704295B (ko)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5117193B2 (ja) 2004-11-03 2013-01-09 バイオヴァイト オーストラリア ピーティーワイ リミテッド アルスロスピラをベースとする組成物及びその利用
JP5195395B2 (ja) * 2008-12-19 2013-05-08 株式会社リコー 画像処理装置、画像処理方法、画像処理プログラム及び記録媒体
GB2472790A (en) * 2009-08-18 2011-02-23 Laurence Christian Hayes Dermatological preparations comprising microbes.
DE102011107307A1 (de) * 2011-07-06 2013-01-10 Ocean Research & Development Gmbh Verfahren zur Herstellung eines pharmazeutisch wirksamen Extrakts aus Arthrospira spec.
WO2014165253A1 (en) * 2013-03-12 2014-10-09 Nbip, Llc Compositions and methods for preventing infection of a wound and for advancing the healing process
CA2927378A1 (en) * 2013-11-05 2015-05-14 Nestec S.A. Use of glucosamine-enriched plant compositions
DE102013112696A1 (de) * 2013-11-18 2015-05-21 Ocean Research & Development Gmbh Verwendung eines Extrakts aus Arthrospira spec. gegen Methicillin-resistente Staphylococcus aureus-Stämme
PL3086797T3 (pl) 2013-12-23 2018-11-30 Medical Brands Research B.V. Kompozycja dermatologiczna na bazie wyciągów z alg i liści oliwki
FR3025213A1 (fr) * 2014-08-28 2016-03-04 Algobiotech Procede d'induction de la synthese des phycobiliproteines
CN110769840A (zh) * 2017-05-23 2020-02-07 碧澳维特澳大利亚股份有限公司 源自节螺藻属的提取物及其用途
JP2019092413A (ja) * 2017-11-21 2019-06-20 株式会社タベルモ 飲食品用藻類含有組成物及びその製造方法
CN107823106A (zh) * 2017-11-28 2018-03-23 广东易康正道大健康生命科技有限公司 一种促进面部微循环及表皮修复的剃须乳液及其制备方法
EP4161542A4 (en) * 2020-06-03 2024-08-14 Biovite Australia Pty Ltd ANTIMICROBIAL AND ANTI-INFLAMMATORY COMPOSITION COMPRISING ARTHROSPIRA EXTRACTS AND AN ORGANIC ACID
EP3967318A1 (en) * 2020-09-14 2022-03-16 Bionou Research, S.L. Probiotic compositions for the treatment of acne

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR90002E (fr) 1963-08-16 1967-09-29 Inst Francais Du Petrole Procédé de culture d'algues en milieu synthétique
US3403471A (en) 1965-02-18 1968-10-01 Inst Francais Du Petrole Method of culturing algae in an artificial medium
FR1557635A (ko) 1967-04-20 1969-02-21
JPS5221336A (en) * 1975-08-12 1977-02-17 Kanto Taale Seihin Kk Cosmetic utilizing spirulina alga
JPS5231836A (en) 1975-09-05 1977-03-10 Ryuzo Yoshida Beauty packs containing spirulina platensis
JPS54140737A (en) * 1978-04-24 1979-11-01 Kimiko Horiie Hair tonic
JPH05112461A (ja) * 1991-07-01 1993-05-07 Nippon Oil Co Ltd 抗ウイルス性抽出物
US5443844A (en) * 1992-12-03 1995-08-22 Mcdaniel; William R. Linoleic acid preparations for topical treatment of acne vulgaris
FR2706305B1 (fr) 1993-06-15 1995-08-25 Payot Laboratoires Dr Ng Composition cosmétique ou pharmaceutique anti-radicaux libres pour application topique.
JPH08301772A (ja) * 1995-05-01 1996-11-19 Nippon Oil Co Ltd 硫酸多糖類のカルシウム塩を含んで成る抗ウイルス剤
JPH0967265A (ja) * 1995-08-31 1997-03-11 Nippon Oil Co Ltd 魚類病原ウイルスに対する抗ウイルス剤
JP4181638B2 (ja) 1996-12-09 2008-11-19 バイオバイト オーストラリア プロプライエタリー リミテッド 生物学的制御方法
US6479277B2 (en) * 1997-06-04 2002-11-12 Cellular Improvements Ltd. Method and apparatus for disruption of biological material
NZ328013A (en) 1997-06-04 1999-06-29 Cellular Improvements Ltd Subs Method and apparatus for preparing an homogenous mixture of disrupted biological cells by using a rapid pressure change of an inert gas
FR2768744B1 (fr) * 1997-09-19 2000-10-13 Quoc Kiet Pham Procede de culture mixotrophique de spirulines pour la production d'une biomasse riche en acides gras polyinsatures omega 6 et/ou en sulfolipides
DE10059107A1 (de) 1999-12-23 2001-06-28 Henkel Kgaa Extrakt aus der Blaualge Spirulina und seine Verwendung in kosmetischen und dermatologischen Mitteln zur Haut- und Körperpflege
JP2001224332A (ja) * 2000-02-15 2001-08-21 Minoru Yoneda 歯周疾患対応食品
MD2516C2 (ro) 2004-04-07 2005-03-31 Валериу РУДИК Remediu medicamentos antiinflamator, antiseptic şi antifungic sub formă de gel
JP5117193B2 (ja) 2004-11-03 2013-01-09 バイオヴァイト オーストラリア ピーティーワイ リミテッド アルスロスピラをベースとする組成物及びその利用

Also Published As

Publication number Publication date
ZA200704295B (en) 2008-08-27
PL1814977T3 (pl) 2014-12-31
CN101068917A (zh) 2007-11-07
PL2502983T3 (pl) 2017-11-30
KR101350764B1 (ko) 2014-02-19
EP1814977B1 (en) 2014-06-18
RU2412990C2 (ru) 2011-02-27
RU2007120514A (ru) 2008-12-10
US20090123429A1 (en) 2009-05-14
ES2503340T3 (es) 2014-10-06
DK2502983T3 (en) 2017-09-25
EP2502983A1 (en) 2012-09-26
DK1814977T3 (da) 2014-09-29
PT1814977E (pt) 2014-09-23
EP1814977A4 (en) 2009-11-11
KR20070092214A (ko) 2007-09-12
JP2008518977A (ja) 2008-06-05
EP1814977A1 (en) 2007-08-08
US8808706B2 (en) 2014-08-19
EP2502983B1 (en) 2017-06-07
CN101068917B (zh) 2010-12-15
NZ554897A (en) 2008-11-28
JP5117193B2 (ja) 2013-01-09
SI1814977T1 (sl) 2014-11-28
CA2627187C (en) 2015-12-08
ES2639821T3 (es) 2017-10-30
WO2006047830A1 (en) 2006-05-11
CY1115690T1 (el) 2017-01-25
CA2627187A1 (en) 2006-05-11

Similar Documents

Publication Publication Date Title
HK1114876A1 (en) Arthrospira-based compositions and uses thereof
WO2006113942A3 (en) Method of inhibiting cathepsin activity
WO2006093348A3 (en) Method and composition for treating peripheral vascular diseases
WO2009027820A3 (en) Substituted-quinoxaline-type-piperidine compounds and the uses thereof
WO2009026176A3 (en) Antiinfective flavononol compounds and methods of use thereof
WO2008100867A3 (en) Novel inhibitors hepatitis c virus replication
GEP20084551B (en) 4-phenylamino-quinazolin-6-yl-amides
WO2008073933A3 (en) 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use
MY140826A (en) Substituted pyrazoline compounds, their preparation and use as medicaments.
MY155649A (en) Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease
DE60325379D1 (de) Zusammensetzung enthaltend 6-Ä3-(1-adamantyl)-4-methoxyphenylÜ-2-naphthanoesäure zur Behandlung dermatologischer Erkrankungen
UA92355C2 (en) urn:schemas-microsoft-com:office:smarttags2,4-DIAMINO-PYRIMIDINES USED AS AURORAINHIBITORS
WO2008070129A3 (en) Compositions and methods for the treatment of inflammatory disease
EP1627635A3 (en) Benzothiazolium compounds for use in methods of inhibiting NO production and TNF alpha and treating coronaviral infection
UA92894C2 (ru) Способ приготовления и применения композиции адсорбента фосфата, адсорбент фосфата, композиция адсорбента фосфата
WO2010071826A3 (en) Methods for treating osteoclast-related disease, compounds and compositions thereof
NO20082096L (no) Azaindol-2-karboksamidderivativer
TW200738699A (en) 4-Substituted pyrazoline compounds, their preparation and use as medicaments
TW200640911A (en) Novel, long acting betamimetics for the treatment of respiratory diseases
TW200726763A (en) Novel compound
WO2008086452A3 (en) Treatment and prevention of alzheimer's disease
MY146802A (en) Novel drugs for treating respiratory diseases
EA200970436A1 (ru) Соединения карбамата для лечения депрессии
WO2004087700A8 (fr) Derives du benzenesulfonamide, leur procede de preparation et leur utilisation de la douleur
WO2008023003A8 (de) Arzneimittelkombinationen zur behandlung von atemwegserkrankungen